- Home
- GROW vs BNR Comparison
GROW vs BNR Comparison
Compare GROW & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- BNR
- Stock Information
- Founded
- GROW 1968
- BNR 2014
- Country
- GROW United States
- BNR China
- Employees
- GROW N/A
- BNR N/A
- Industry
- GROW Investment Managers
- BNR Medical Specialities
- Sector
- GROW Finance
- BNR Health Care
- Exchange
- GROW Nasdaq
- BNR Nasdaq
- Market Cap
- GROW 31.8M
- BNR 38.3M
- IPO Year
- GROW N/A
- BNR 2020
- Fundamental
- Price
- GROW $2.45
- BNR $4.60
- Analyst Decision
- GROW
- BNR
- Analyst Count
- GROW 0
- BNR 0
- Target Price
- GROW N/A
- BNR N/A
- AVG Volume (30 Days)
- GROW 44.9K
- BNR 29.7K
- Earning Date
- GROW 09-09-2025
- BNR 08-21-2025
- Dividend Yield
- GROW 3.67%
- BNR N/A
- EPS Growth
- GROW N/A
- BNR N/A
- EPS
- GROW 0.01
- BNR N/A
- Revenue
- GROW $8,932,000.00
- BNR $72,112,038.00
- Revenue This Year
- GROW N/A
- BNR $136.32
- Revenue Next Year
- GROW N/A
- BNR N/A
- P/E Ratio
- GROW $232.40
- BNR N/A
- Revenue Growth
- GROW N/A
- BNR 0.53
- 52 Week Low
- GROW $2.02
- BNR $2.18
- 52 Week High
- GROW $2.73
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- GROW 52.72
- BNR 63.77
- Support Level
- GROW $2.38
- BNR $3.06
- Resistance Level
- GROW $2.49
- BNR $3.50
- Average True Range (ATR)
- GROW 0.09
- BNR 0.21
- MACD
- GROW -0.01
- BNR 0.05
- Stochastic Oscillator
- GROW 24.24
- BNR 95.65
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.